ARYx Therapeutics, Inc. Stock Other OTC
Equities
ARYX
US0433871094
Biotechnology & Medical Research
Financials (USD)
Sales 2008 | 19.72 | Sales 2009 | - | Capitalization | 88.66M |
---|---|---|---|---|---|
Net income 2008 | -31M | Net income 2009 | -33M | EV / Sales 2008 | 4,019,605 x |
Net cash position 2008 | 29.9 | Net Debt 2009 | 2.37 | EV / Sales 2009 | - |
P/E ratio 2008 |
-1.76
x | P/E ratio 2009 |
-2.66
x | Employees | - |
Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |